Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
satraplatin
ORPLATNA
-
semuloparin sodium
MULSEVO
-
serelaxin
REASANZ
C01DX21 -
shingles (herpes zoster) vaccine (live)
ZOSTAVAX
J07BK02 -
simeprevir
OLYSIO
J05AE14 -
sinapultide
SURFAXIN
-
sirukumab
PLIVENSIA
L04AC -
sitaxentan sodium
THELIN
C02KX03 -
solithromycin
SOLITHROMYCIN TRISKEL EU SERVICES
J01FA -
sotrovimab
XEVUDY
J06BD05 -
strontium ranelate
OSSEOR
M05BX03 -
sulesomab
LEUKOSCAN
VO4D -
surufatinib
SEVSURY
L01EX01 -
tanezumab
RAYLUMIS
N02 -
tarlatamab
IMDYLLTRA
L01FX33 -
tegaserod
ZELNORM
A03AE02 -
tesamorelin
EGRIFTA
-
thrombin alfa
RECOTHROM
-
tilmanocept
LYMPHOSEEK
V09IA09 -
tixagevimab
EVUSHELD
-
tolebrutinib
CENRIFKI
-
trastuzumab duocarmazine
JIVADCO
-
trenonacog alfa
IXINITY
B02BD12 -
troriluzole
DAZLUMA
N07XX
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.